Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 5, 2015, Pages

  Nistor, Ionut ^a,b   Palmer, Suetonia C ^c   Craig, Jonathan C ^d,e   Saglimbene, Valeria ^f   Vecchio, Mariacristina ^f   Covic, Adrian ^a   Strippoli, Giovanni F M ^e,g,h,i  

^a GRIGORE T POPA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c UNIVERSITY OF OTAGO   (New Zealand)

^d UNIVERSITY OF SYDNEY   (Australia)

^e CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^f MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^g UNIVERSITY OF BARI   (Italy)

^h Diaverum Medical Scientific Office   (Sweden)

ⁱ Diaverum Academy   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETATE FREE BIOFILTRATION; BIOFILTRATION; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CIRCULATION; DIASTOLIC BLOOD PRESSURE; END STAGE RENAL DISEASE; FOLLOW UP; HEADACHE; HEMODIAFILTRATION; HEMODIALYSIS; HEMOFILTRATION; HOSPITALIZATION; HUMAN; HYPOTENSION; INTERVENTION STUDY; MORTALITY; NAUSEA; POPULATION RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; VOMITING; WELLBEING; ADULT; ADVERSE EFFECTS; COMPARATIVE STUDY; FEMALE; KIDNEY FAILURE, CHRONIC; MALE; META ANALYSIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ADULT; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FEMALE; HEMODIAFILTRATION; HEMOFILTRATION; HOSPITALIZATION; HUMANS; HYPOTENSION; KIDNEY FAILURE, CHRONIC; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84945405422     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006258.pub2     Document Type: Review

References (310)

1. Altieri P, Sorba G, Bolasco P, Ledebo I, Ganadu M, Ferrara R, et al. Comparison between hemofiltration and hemodiafiltration in a long-term prospective cross-over study. Journal of Nephrology 2004;17(3):414-22. [MEDLINE: 15365963]
2. Bammens B, Evenepoel P, Claes K, Kuypers D, Maes B, Verbeke K, et al. Middle molecule and protein bound toxin removal by an FX-class dialyser in haemodialysis and haemodiafiltration: a randomised cross-over study [abstract]. Nephrology Dialysis Transplantation 2003;18(Suppl 4):757. [CENTRAL: CN-00444322]
3. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y. Protein bound solutes: explaining the dissociation between urea-reduction ratio and patient outcome? [abstract no: SU-PO911]. Journal of the American Society of Nephrology 2003;14(Nov):736A. [CENTRAL: CN-00644357]
4. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y. Removal of protein bound solutes by convective transport: a randomized cross-over study [abstract no: SU-PO905]. Journal of the American Society of Nephrology 2003;14(Nov):734A. [CENTRAL: CN-00644358]
5. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y. Removal of the protein-bound solute p-cresol by convective transport: a randomized crossover study. American Journal of Kidney Diseases 2004;44(2):278-85. [MEDLINE: 15264186]
6. Basile C, Giordano R, Montanaro A. Effect of acetate-free biofiltration (AFB) on renal anemia: a prospective cross-over study [abstract]. Journal of the American Society of Nephrology 2001;12:352A.
7. Basile C, Giordano R, Montanaro A, De Maio PD, De Padova FD, Marangi AL, et al. Effect of acetate-free biofiltration on the anaemia of haemodialysis patients: a prospective cross-over study. Nephrology Dialysis Transplantation 2001;16(9):1914-9. [MEDLINE: 11522879]
8. Basile C, Giordano R, Montanaro A, De Padova F, Marangi AL. Effect of acetate-free biofiltration (AFB) on renal anemia: a prospective cross-over study [abstract]. 38th Congress. European Renal Association. European Dialysis and Transplantation Association; 2001 Jun 24-27; Vienna, Austria. 2001:206. [CENTRAL: CN-00444349]
9. Beerenhout CH, Luik AJ, Jeuken-Mertens SG, Bekers O, Menheere P, Hover L, et al. Pre-dilution on-line haemofiltration vs low-flux haemodialysis: a randomized prospective study. Nephrology Dialysis Transplantation 2005;20(6):1155-63. [MEDLINE: 15784639]
10. Kooman J, Beerenhout C, Luik A, van der Sande F, Leunissen K. Predilution on-line hemofiltration versus hemodialysis: a randomised study [abstract no: SA-PO458]. Journal of the American Society of Nephrology 2004;15(Oct):403A. [CENTRAL: CN-00626039]
11. Meert N, Beerenhout C, De Smet R, Kooman J, Vanholder R. Removal of protein-bound uremic solutes by predilution on-line hemofiltration [abstract no: MP401]. Nephrology Dialysis Transplantation 2005;20(Suppl 5):v334.
12. Meert N, Beerenhout C, De Smet R, Kooman J, Vanholder R. Removal of protein-bound uremic solutes by predilution on-line hemofiltration [abstract no: SA-PO285]. Journal of the American Society of Nephrology 2004;15(Oct):363A.
13. Bolasco P, Altieri P, Andrulli S, Basile C, Di Filippo S, Feriani M, et al. Convection versus diffusion in dialysis: an Italian prospective multicentre study. Nephrology Dialysis Transplantation 2003;18 Suppl 7:vii50-4. [MEDLINE: 12953031]
14. Locatelli F, Altieri P, Andrulli S, Bolasco P, Sau G, Pedrini LA, et al. Hemofiltration and hemodiafiltration reduce intradialytic hypotension in ESRD. Journal of the American Society of Nephrology 2010;21(10):1798-807. [MEDLINE: 20813866]
15. Locatelli F, Altieri P, Andrulli S, Sau G, Bolasco P, Pedrini LA, et al. Phosphate levels in patients treated with low-flux haemodialysis, pre-dilution haemofiltration and haemodiafiltration: post hoc analysis of a multicentre, randomized and controlled trial. Nephrology Dialysis Transplantation 2014;29(6):1239-46. [MEDLINE: 24557989]
16. Locatelli F, Altieri P, Andrulli S, Sau G, Bolasco P, Pedrini LA, et al. Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial. Nephrology Dialysis Transplantation 2012;27(9):3594-600. [MEDLINE: 22622452]
17. Coll E, Perez-Garcia R, Martin de Francisco AL, Galceran J, Garcia-Osuna R, Martin-Malo A, et al. Acetate-free on-line PHF: how to improve hyperacetatemia and haemodynamic tolerance [PHF on-line sin acetato: como mejorar la hiperacetatemia y la tolerancia hemodinamica]. Nefrologia 2009;29(2):156-62. [MEDLINE: 19396322]
18. Bots ML, Den Hoedt C, Pc Grooteman M, Van Der Weerd NC, Mazairac AH, Levesque R, et al. The effect of online hemodiafiltration on systemic inflammation in a randomized controlled trial: Results from the convective transport study (CONTRAST) [abstract]. Nephrology Dialysis Transplantation 2012;27(Suppl 2):ii206. [EMBASE: 70765903]
19. Gritters M, Schoorl M, Schoorl M, Bartels PC, Grooteman MP, Nube MJ, et al. Platelet activation is increased in hemodiafiltration (HDF): a subgroup analysis of the CONvective TRAnsport STudy (CONTRAST) [abstract no: F-FC313]. Journal of the American Society of Nephrology 2008;19(Abstracts Issue):70A.
20. Gritters M, Vroling L, Grooteman MP, de Haas RR, Broxterman HJ, Nube MJ, et al. Hemodiafiltration (HDF) increases the number of circulating hematopoietic progenitor cells (HPC) and lowers numbers of circulating cells with endothelial markers: a subgroup analysis of CONTRAST (CONvective TRAnsport Study) [abstract no: F-PO680]. Journal of the American Society of Nephrology 2007;18(Abstracts):249A.
21. Gritters-van den Oever M, Grooteman MP, Bartels PC, Blankestijn PJ, Bots ML, van den Dorpel MA, et al. Post-dilution haemodiafiltration and low-flux haemodialysis have dissimilar effects on platelets: a side study of CONTRAST. Nephrology Dialysis Transplantation 2009;24(11):3461-8. [MEDLINE: 19561150]
22. Grooteman MP, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AH, et al. Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. Journal of the American Society of Nephrology 2012;23(6):1087-96. [MEDLINE: 22539829]
23. Grooteman MP, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AH, et al. Online hemodiafiltration versus low-flux hemodialysis: effects on all-cause mortality and cardiovascular events in a randomized controlled trial. The Convective Transport Study (CONTRAST) [abstract]. NDT Plus 2011;4(Suppl 2):4.2S.1.
24. Mazairac AH, Blankestijn PJ, Grooteman MP, Penne EL, van der Weerd NC, den Hoedt CH, et al. The cost-utility of haemodiafiltration versus haemodialysis in the Convective Transport Study. Nephrology Dialysis Transplantation 2013;28(7):1865-73. [MEDLINE: 23766337]
25. Mazairac AH, Bots ML, de Wit GA, de Jong B, Boeschoten W, van der Weerd NC, et al. Improvement of health-related quality of life (QoL) in hemodialysis (HD) patients over the past decade in the Netherlands [abstract no: TH-PO811]. Journal of the American Society of Nephrology 2008;19(Abstracts Issue):293A.
26. Mazairac AH, Grooteman MP, Blankestijn PJ, Penne EL, van der Weerd NC, den Hoedt CH, et al. Differences in quality of life of hemodialysis patients between dialysis centers. Quality of Life Research 2012;21(2):299-307. [MEDLINE: 21633878]
27. Mazairac AH, de Wit GA, Grooteman MP, Penne EL, van der Weerd NC, den Hoedt CH, et al. Clinical performance targets and quality of life in hemodialysis patients. Blood Purification 2012;33(1-3):73-9. [MEDLINE: 22212621]
28. Mazairac AH, de Wit GA, Grooteman MP, Penne EL, van der Weerd NC, den Hoedt CH, et al. Effect of hemodiafiltration on quality of life over time. Clinical Journal of the American Society of Nephrology: CJASN 2013;8(1):82-9. [MEDLINE: 23124783]
29. Mazairac AH, de Wit GA, Grooteman MP, Penne EL, van der Weerd NC, van den Dorpel MA, et al. A composite score of protein-energy nutritional status predicts mortality in haemodialysis patients no better than its individual components. Nephrology Dialysis Transplantation 2011;26(6):1962-7. [MEDLINE: 20947533]
30. Mostovaya IM, Bots ML, van den Dorpel MA, Goldschmeding R, den Hoedt CH, Kamp O, et al. Left ventricular mass in dialysis patients, determinants and relation with outcome. Results from the COnvective TRansport STudy (CONTRAST). PLoS ONE [Electronic Resource] 2014;9(2):e84587. [MEDLINE: 24505249]
31. Mostovaya IM, Bots ML, van den Dorpel MA, Grooteman MP, Kamp O, Levesque R, et al. A randomized trial of hemodiafiltration and change in cardiovascular parameters. Clinical Journal of the American Society of Nephrology: CJASN 2014;9(3):520-6. [MEDLINE: 24408114]
32. Penne EJ, Blankestijn PJ, Bots ML, van den Dorpel MA, Grooteman MP, Nube MJ, et al. New study evaluating online haemodiafiltration for the reduction of cardiovascular morbidity and mortality in patients undergoing chronic haemodialysis [Nieuw onderzoek naar online-hemodiafiltratie voor de vermindering van cardiovasculaire morbiditeit en mortaliteit bij patienten die chronisch worden behandeld met hemodialyse]. Nederlands Tijdschrift voor Geneeskunde 2006;150(28):1583-5. [MEDLINE: 16886698]
33. Penne EL, Blankestijn PJ, Bots ML, van den Dorpel MA, Grooteman MP, Nube MJ, et al. Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic hemodialysis patients - the Dutch CONvective TRAnsport STudy (CONTRAST): rationale and design of a randomised controlled trial [ISRCTN38365125]. Current Controlled Trials in Cardiovascular Medicine 2005;6(1):8. [MEDLINE: 15907201]
34. Penne EL, Blankestijn PJ, Bots ML, van den Dorpel MA, Grooteman MP, Nube MJ, et al. Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic hemodialysis patients: design and rationale of the Dutch CONvective TRAnsport STudy (CONTRAST) [abstract no: SA-PO471]. Journal of the American Society of Nephrology 2004;15(Oct):406A. [CENTRAL: CN-00550574]
35. Penne EL, Blankestijn PJ, Bots ML, van den Dorpel MA, Grooteman MP, Nube MJ, et al. Resolving controversies regarding hemodiafiltration versus hemodialysis: the Dutch Convective Transport Study. Seminars in Dialysis 2005;18(1):47-51. [MEDLINE: 15663765]
36. Penne EL, van der Weerd NC, Blankestijn PJ, van den Dorpel MA, Grooteman MP, Nube MJ, et al. Role of residual kidney function and convective volume on change in beta2-microglobulin levels in hemodiafiltration patients. Clinical Journal of the American Society of Nephrology: CJASN 2010;5(1):80-6. [MEDLINE: 19965537]
37. Penne EL, van der Weerd NC, Grooteman MP, Nube MJ, Bots ML, van den Dorpel MA, et al. Pronounced decrease of beta-2 microglobulin by online hemodiafiltration in patients without residual renal function [abstract no: TH-PO634]. Journal of the American Society of Nephrology 2008;19(Abstracts Issue):249A.
38. Penne EL, van der Weerd NC, van den Dorpel MA, Grooteman MP, Levesque R, Nube MJ, et al. Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST). American Journal of Kidney Diseases 2010;55(1):77-87. [MEDLINE: 19962805]
39. Penne L, Blankestijn P, Bots M, Van den Dorpel R, Grooteman M, Nube M, et al. The CONvective TRAnsport STudy (CONTRAST) is designed to detect differences in mortality and cardiovascular disease between online hemodiafiltration and hemodialysis: preliminary findings on proof of principle [abstract no: SA-PO811]. Journal of the American Society of Nephrology 2005;16:734A.
40. Penne L, Blankestijn P, Bots M, van den Dorpel MA, Grooteman M, Nube M, et al. Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic dialysis patients: design and preliminary baseline characteristics of the CONvective TRAnsport STudy (CONTRAST) [abstract no: T-PO40054]. Nephrology 2005;10(Suppl 1):A189. [CENTRAL: CN-00601971]
41. Van der Weerd NC, Blankestijn PJ, Bots ML, van den Dorpel RA, Grooteman MP, Nube MJ, et al. Dose dependent decrease in beta-2-microglobulin levels in patients treated with online hemodiafiltration in the Dutch CONvective TRAnsport STudy (CONTRAST) [abstract no: S-PO-0130]. 4th World Congress of Nephrology.19th International Congress of the International Society of Nephrology (ISN); 2007 Apr 21-25; Rio de Janeiro, Brazil. 2007:83.
42. den Hoedt CH, Bots ML, Grooteman MP, Mazairac AH, Penne EL, van der Weerd NC, et al. Should we still focus that much on cardiovascular mortality in end stage renal disease patients? The CONvective TRAnsport STudy. PLoS ONE [Electronic Resource] 2013;8(4):e61155. [MEDLINE: 23620729]
43. den Hoedt CH, Bots ML, Grooteman MP, van der Weerd NC, Penne EL, Mazairac AH, et al. Clinical predictors of decline in nutritional parameters over time in ESRD. Clinical Journal of the American Society of Nephrology: CJASN 2014;9(2):318-25. [MEDLINE: 24458074]
44. van der Weerd N, Blankestijn P, Bots M, Van den Dorpel R, Grooteman M, Nube M, et al. Dose dependent decrease in beta-2-microglobulin (b2M) levels in patients treated with online hemodiafiltration (HDF) in the Dutch CONvective TRAnsport STudy (CONTRAST) [abstract no: F-FC077]. Journal of the American Society of Nephrology 2006;17(Abstracts):53A. [CENTRAL: CN-00601973]
45. van der Weerd N, Penne E, Blankestijn P, Bots M, Van den Dorpel R, Grooteman M, et al. No increase in erythropoietin (EPO) sensitivity despite increased middle molecular weight (MMV) clearance in patients treated with online hemodiafiltration (HDF) in the Dutch CONvective TRAnsport STudy (CONTRAST) [abstract no: F-PO826]. Journal of the American Society of Nephrology 2007;18(Abstracts):283A.
46. van der Weerd N, Penne L, Blankestijn P, Bots M, van den Dorpel R, Grooteman M. Determinants of epoetin (EPO) sensitivity in patients treated with online hemodiafiltration (HDF) or conventional hemodialysis (HD) in the Dutch CONvective TRAnsport STudy (CONTRAST) [abstract no: TH-PO722]. Journal of the American Society of Nephrology 2008;19(Abstracts Issue):270A.
47. van der Weerd N, Penne L, Grooteman M, Levesque R, Van den Dorpel R, Blankestijn P, et al. Resistance to erythropoiesis stimulating agents (ESA) in a randomized controlled trial (CONTRAST study) [abstract no: OSU052]. NDT Plus 2010;3(Suppl 3):iii296.
48. van der Weerd NC, Grooteman MP, Bots ML, van den Dorpel MA, den Hoedt CH, Mazairac AH, et al. Hepcidin-25 in chronic hemodialysis patients is related to residual kidney function and not to treatment with erythropoiesis stimulating agents. PLoS ONE [Electronic Resource] 2012;7(7):e39783. [MEDLINE: 22808058]
49. van der Weerd NC, Grooteman MP, Bots ML, van den Dorpel MA, den Hoedt CH, Mazairac AH, et al. Hepcidin-25 is related to cardiovascular events in chronic haemodialysis patients. Nephrology Dialysis Transplantation 2013;28(12):3062-71. [MEDLINE: 23147161]
50. van der Weerd NC, den Hoedt CH, Blankestijn PJ, Bots ML, van den Dorpel MA, Levesque R, et al. Resistance to erythropoiesis stimulating agents in patients treated with online hemodiafiltration and ultrapure low-flux hemodialysis: results from a randomized controlled trial (CONTRAST). PLoS ONE [Electronic Resource] 2014;9(4):e94434. [MEDLINE: 24743493]
51. Cristofano C, Vernaglione L, Perniola MA, Lo Barco C, Muscogiuri P, Chimienti S. Cystatin C, beta2microglobulin (B2MCG) and C reactive protein (CRP) in two separate chambers hemodiafiltration and online endogenous liquid reinfusion (HFR) and in low flux polysulphone bicarbonate conventional hemodialysis (LFHD) [abstract]. 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:371. [CENTRAL: CN-00550765]
52. Vernaglione L, Cristofano C, Chimienti S. Cystatin C (CYS), b2-microglobulin (MIC) and C-reactive protein (CRP) behaviours during hemodiafiltration with online endogenous liquid reinfusion (HFR) and low-flux polysulphone bicarbonate dialysis (BD) [abstract no: SA-PO702]. Journal of the American Society of Nephrology 2006;17(Abstracts):722A. [CENTRAL: CN-00644356]
53. Ding F, Ahrenholz P, Winkler RE, Ramlow W, Tiess M, Michelsen A. On-line hemodiafiltration versus acetate-free biofiltration: a prospective cross-over study [abstract]. 38th Congress. European Renal Association. European Dialysis and Transplantation Association; 2001 Jun 24-27; Vienna, Austria. 2001:284. [CENTRAL: CN-00460648]
54. Ding F, Ahrenholz P, Winkler RE, Ramlow W, Tiess M, Michelsen A, et al. Online hemodiafiltration versus acetate-free biofiltration: A prospective crossover study. Artificial Organs 2002;26(2):169-80. [MEDLINE: 11879247]
55. Eiselt J, Racek J, Opatrny K Jr. The effect of hemodialysis and acetate-free biofiltration on anemia. International Journal of Artificial Organs 2000;23(3):173-80. [MEDLINE: 10795662]
56. Maduell F, Moreso F, Pons M, Ramos R, Mora-Macia J, Carreras J, et al. High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients. Journal of the American Society of Nephrology 2013;24(3):487-97. [MEDLINE: 23411788]
57. Maduell F, Moreso F, Pons M, Ramos R, Mora-Macia J, Foraster A, et al. Design and patient characteristics of ESHOL study, a Catalonian prospective randomized study. Journal of Nephrology 2011;24(2):196-202. [MEDLINE: 20602331]
58. Fox SD, Henderson LW. Cardiovascular response during hemodialysis and hemofiltration: thermal, membrane and catecholamine influences. Blood Purification 1993;11(4):224-36. [MEDLINE: 8297564]
59. Kantartzi K, Panagoutsos S, Mourvati E, Roumeliotis A, Leivaditis K, Devetzis V, et al. Can dialysis modality influence quality of life in chronic hemodialysis patients? low-flux hemodialysis versus high-flux hemodiafiltration: a cross-over study. Renal Failure 2013;35(2):216-21. [MEDLINE: 23176401]
60. Jensen D, Karamperis N, Jensen JD. Hemodynamic stability during pre-HDF and lowflux HD at temperature controlled conditions using high calcium-ion dialysis and replacement fluid. A blinded randomized controlled study [abstract no: SU-PO275]. Journal of the American Society of Nephrology 2004;15(Oct):593A-4A. [CENTRAL: CN-00583242]
61. Jensen JD, Karamperis N, Sloth E. Hemodynamic stability in predilution hemodiafiltration (HDF) compared with lowflux hemodialysis (HD) at temperature controlled conditions - a blind randomized controlled trial [abstract]. Nephrology Dialysis Transplantation 2003;18(Suppl 4):192-3. [: CN-00445915]
62. Karamperis N, Jensen D, Sloth E, Jensen JD. Comparison of predilution hemodiafiltration and low-flux hemodialysis at temperature-controlled conditions using high calcium-ion concentration in the replacement and dialysis fluid. Clinical Nephrology 2007;67(4):230-9. [MEDLINE: 17474559]
63. Karamperis N, Sloth E, Jensen JD. Predilution hemodiafiltration displays no hemodynamic advantage over low-flux hemodialysis under matched conditions. Kidney International 2005;67(4):1601-8. [MEDLINE: 15780117]
64. Lin CL, Huang CC, Chang CT, Wu MS, Hong JJ, Chien CC, et al. Clinical improvement by increased frequency of on-line hemodialfiltration [abstract]. 8th Asian Pacific Congress of Nephrology; 2000 Mar 26-30; Taipei, Taiwan. 2000:194. [CENTRAL: CN-00461180]
65. Lin CL, Huang CC, Chang CT, Wu MS, Hung CC, Chien CC, et al. Clinical improvement by increased frequency of on-line hemodialfiltration. Renal Failure 2001;23(2):193-206. [MEDLINE: 11417951]
66. Lin CL, Yang CW, Chiang CC, Chang CT, Huang CC. Long-term on-line hemodiafiltration reduces predialysis beta-2-microglobulin levels in chronic hemodialysis patients. Blood Purification 2001;193(3):301-7. [MEDLINE: 11244190]
67. Lin CL, Yang CW, Chiang CC, Chang CT, Huang CC. On-line hemodiafiltration reduces pre-dialysis b2-microglobulin levels in chronic hemodialysis patients [abstract]. 8th Asian Pacific Congress of Nephrology; 2000 Mar 26-30; Taipei, Taiwan. 2000:313. [CENTRAL: CN-00461181]
68. Locatelli F, Italian Cooperative Dialysis Study Group. Effect of hemodialysis membranes on serum albumin. American Journal of Kidney Diseases 2001;37(2):455-6. [MEDLINE: 11157397]
69. Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, La Greca G, et al. Effects of different membranes and dialysis technologies on patient treatment tolerance and nutritional parameters. The Italian Cooperative Dialysis Study Group. Kidney International 1996;50(4):1293-302. [MEDLINE: 8887291]
70. Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, La Greca G, et al. The effects of different membranes and dialysis technologies on the treatment tolerance and nutritional parameters of hemodialysis patients [abstract no: A1031]. Journal of the American Society of Nephrology 1996;7(9):1454. [CENTRAL: CN-00583453]
71. Locatelli F, Mastrangelo F, Redaelli B, Ronco C, Marcelli D, Orlandini G. The effects of different membranes and dialysis technologies on the treatment tolerance and nutritional parameters of hemodialysed patients. Design of a prospective randomised multicentre trial. Journal of Nephrology 1994;7(2):123-9. [EMBASE: 1994156257]
72. Lornoy W, Becaus I, Billiouw JM, Sierens L, Van Malderen P, D'Haenens P. On-line haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations. Nephrology Dialysis Transplantation 2000;15 Suppl 1:49-54. [MEDLINE: 10737167]
73. Lornoy W, Becaus I, Billiouw JM, Sierens L, Van Malderen P, Vrouwziekenhuis OL. Remarkable removal of b2-microglobulin, but not of small molecules by on-line hemodiafiltration (HDF). Nephrology Dialysis Transplantation 1997;12(3):631. [CENTRAL: CN-00626022]
74. Lornoy W, Becaus I, Billiouw JM, Sierens L, Vrouwziekenhuis OL. Remarkable removal of b2-microglobulin, but not of small molecules by on-line hemodiafiltration (HDF) [abstract]. Journal of the American Society of Nephrology 1995;6(3):546. [CENTRAL: CN-00484892]
75. Lornoy W, Becaus I, Billiouw JM, Sierens L, van Malderen P. Remarkable removal of beta-2-microglobulin by on-line hemodiafiltration. American Journal of Nephrology 1998;18(2):105-8. [MEDLINE: 9569951]
76. Mandolfo S, Borlandelli S, Imbasciati E, Badalamenti S, Graziani G, Sereni L, et al. Pilot study to assess increased dialysis efficiency in patients with limited blood flow rates due to vascular access problems. Hemodialysis International 2008;12(1):55-61. [MEDLINE: 18271842]
77. Meert N, Dhondt A, Eloot S, Vanholder R. Effective removal of uremic solutes by different convective strategies: a prospective cross-over trial [abstract no: F-PO672]. Journal of the American Society of Nephrology 2007;18(Abstracts):247A-8A.
78. Meert N, Eloot S, Waterloos MA, Van Landschoot M, Dhondt A, Glorieux G, et al. Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial. Nephrology Dialysis Transplantation 2009;24(2):562-70. [MEDLINE: 18809977]
79. Movilli E, Camerini C, Zein H, D'Avolio G, Sandrini M, Strada A, et al. A prospective comparison of bicarbonate dialysis, hemodiafiltration, and acetate-free biofiltration in the elderly. American Journal of Kidney Diseases 1996;27(4):541-7. [MEDLINE: 8678065]
80. Noris M, Todeschini M, Casiraghi F, Minetti L, Imberti B, Cereda C, et al. Effect of acetate (AHD), bicarbonate (BHD) dialysis and acetate free biofiltration (AFB) on nitric oxide synthesis: implications for dialysis hypotension [abstract]. Journal of the American Society of Nephrology 1996;7(9):1493. [CENTRAL: CN-00446974]
81. Noris M, Todeschini M, Casiraghi F, Roccatello D, Martina G, Minetti L, et al. Effect of acetate, bicarbonate dialysis and acetate free biofiltration on nitric oxide synthesis: implications for dialysis hypotension. American Journal of Kidney Diseases 1998;32(1):115-24. [MEDLINE: 9669432]
82. Ohtake T, Oka M, Ishioka K, Honda K, Mochida Y, Maesato K, et al. Cardiovascular protective effects of on-line hemodiafiltration: comparison with conventional hemodialysis. Therapeutic Apheresis & Dialysis 2012;16(2):181-8. [MEDLINE: 22458399]
83. Casino F, Pedrini LA, Lopez T, De Cristofaro V, Conte F. Comparing dialysis dose in haemodialysis and online haemodiafiltration. A multicentre randomized cross-over study [abstract no: SP701]. Nephrology Dialysis Transplantation 2006;21(Suppl 4):iv251.
84. De Cristofaro V, Pedrini LA, Casino F, Campolo A, Borzumati M, Prencipe MA, et al. High efficiency on-line haemodiafiltration improves control of secondary hyperparathyroidism. A multicentre randomized cross-over study [abstract no: SP699]. Nephrology Dialysis Transplantation 2006;21(Suppl 4):iv251.
85. Pedrini LA, De Cristofaro V, Casino F, Conte F, Borzumati M, Campolo A, et al. Effects of online haemodiafiltration on cardiovascular risk factors. A multicentre randomized cross-over study [abstract no: MP335]. Nephrology Dialysis Transplantation 2006;21(Suppl 4):iv411.
86. Pedrini LA, De Cristofaro V, Comelli M, Casino FG, Prencipe M, Baroni A, et al. Long-term effects of high-efficiency on-line haemodiafiltration on uraemic toxicity. A multicentre prospective randomized study. Nephrology Dialysis Transplantation 2011;26(8):2617-24. [MEDLINE: 21245130]
87. Alvestrand A, Gutierrez A, Hagerman I, Ledebo I, Mattsson E, Dam Jensen J, et al. Hemofiltration delays deterioration of left ventricular hypertrophy in incident dialysis patients. Initial report from PROFIL, a prospective randomized study comparing hemofiltration with hemodialysis [abstract no: SAP302]. Nephrology Dialysis Transplantation 2007;22(Suppl 6):vi333. [CENTRAL: CN-00653728]
88. Alvestrand A, Ledebo I, Hagerman I, Wingren K, Mattsson E, Qureshi AR, et al. Left ventricular hypertrophy in incident dialysis patients randomized to treatment with hemofiltration or hemodialysis: results from the ProFil study. Blood Purification 2011;32(1):21-9. [MEDLINE: 21252503]
89. Gutierrez A, Alvestrand A, Ledebo I, Dam Jensen J, Wingren K, the PROFIL Study Group. Hemofiltration is adequate at low Kt/V. Initial report from PROFIL, a prospective, randomized study comparing hemofiltration with hemodialysis [abstract no: FP340]. Nephrology Dialysis Transplantation 2007;22(Suppl 6):vi132.
90. Righetti M, Filiberti O, Ranghino A, Ferrario G, Milani S, Serbelloni P, et al. Internal hemodiafiltration versus low-flux bicarbonate dialysis: Results from a long-term prospective study. International Journal of Artificial Organs 2010;33(11):796-802. [MEDLINE: 21140355]
91. Righetti M, Filiberti O, Ranghino A, Ferrario G, Servelloni P, Milani S, et al. Internal haemodiafiltration improves many cardiovascular risk factors: results from a long-term multicenter prospective trial [abstract no: SU375]. World Congress of Nephrology; 2009 May 22-26; Milan, Italy. 2009.
92. Poli A, Tessitore N, Panzetta O, Mantovani W, Esteban J, London G, et al. Acetate-free biofiltration (AFB) and cardiovascular case-fatality rate (CFR) in incident hemodialysis patients (pts) [abstract no: SU-PO562]. Journal of the American Society of Nephrology 2007;18(Abstracts Issue):706A.
93. Santoro A, Panzetta G, Tessitore N, Atti M, Mancini E, Esteban J, et al. A prospective randomised European multicentre study of medium-long run mortality and morbidity comparing acetate-free biofiltration and bicarbonate dialysis. Journal of Nephrology 1999;12(6):375-82. [MEDLINE: 10626827]
94. Santoro A, Panzetta O, Tessitore N, Wizemann V, Perez R, London G, et al. Cardiovascular effects of acetate-free biofiltration (AFB) and conventional bicarbonate dialysis (BD) in chronic dialysis (CD) patients: a controlled randomized European multicenter study [abstract no: FP360]. Nephrology Dialysis Transplantation 2007;22(Suppl 6):vi139.
95. Santoro A, Panzetta O, Tessitore N, Wizemann V, Perez R, Neumann K, et al. A European multicentre RCT on cardiovascular effects of acetate-free biofiltration (AFB) and conventional bicarbonate dialysis (BD) in chronic dialysis (CD) patients [abstract no: SU-FC051]. Journal of the American Society of Nephrology 2007;18(Abstracts):78A.
96. Santoro A, Tessitore N, Panzetta O, Wizemann V, Neumann K, London G, et al. A Controlled Randomized European Multicenter Study (CREMS) on mortality in chronic dialysis (CD) patients: a comparison between acetate-free biofiltration (AFB) and conventional bicarbonate dialysis (BD) [abstract no: FO033]. Nephrology Dialysis Transplantation 2007;22(Suppl 6):vi15.
97. Santoro A, Tessitore N, Wizemann V, Panzetta O, Perez R, Ara JM, et al. Comparison between acetate-free biofiltration (AFB) and bicarbonate dialysis (BD) on mortality in chronic dialysis (CD) patients: a Controlled Randomized European Multicenter Study (CREMS) [abstract no: 767]. Journal of the American Society of Nephrology 2007;18(Abstracts Issue):511A-2A.
98. Tessitore N, Santoro A, Panzetta GO, Wizemann V, Perez-Garcia R, Martinez AJ, et al. Acetate-free biofiltration reduces intradialytic hypotension: a European multicenter randomized controlled trial. Blood Purification 2012;34(3-4):354-63. [MEDLINE: 23406818]
99. Santoro A, Mancini E, Bibiano L, Specchio A, Francioso A, Robaudo C, et al. Online convective therapies: results from a hemofiltration trial. Contributions to Nephrology 2005;149:51-7. [MEDLINE: 15876828]
100. Santoro A, Mancini E, Bolzani R, Boggi R, Cagnoli L, Francioso A, et al. The effect of on-line high-flux hemofiltration versus low-flux hemodialysis on mortality in chronic kidney failure: a small randomized controlled trial. American Journal of Kidney Diseases 2008;52(3):507-18. [MEDLINE: 18617304]
101. Santoro A, Mancini E, MAMHEBI Study Group. Effects of online hemofiltration (OL-HF) versus bicarbonate dialysis (BD) on mortality and morbidity in hemodialysis (HD) patients: a prospective, randomized, multicenter trial (MAMHEBI Study) [abstract no: TH-FC106]. Journal of the American Society of Nephrology 2006;17(Abstracts):24A. [CENTRAL: CN-00653816]
102. Schiffl H, D'Agostini B, Held E. Removal of beta-2 microglobulin by hemodialysis and hemofiltration: a four year follow-up. Biomaterials, Artificial Cells, & Immobilization Biotechnology 1992;20(5):1223-32. [MEDLINE: 1457695]
103. Schiffl H. Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis. European Journal of Medical Research 2007;12(1):26-33. [MEDLINE: 17363355]
104. Schrander-Van der Meer AM, Wee PM, Donker AJ, Dorp WT, Gasthuis K. Improved dialysis efficiency during acetate free biofiltration (AFB) [abstract no: A0858]. Journal of the American Society of Nephrology 1996;7(9):1419. [CENTRAL: CN-00583169]
105. Schrander-vd Meer AM, ter Wee PM, Donker AJ, van Dorp WT. Dialysis efficacy during acetate-free biofiltration. Nephrology Dialysis Transplantation 1998;13(2):370-4. [MEDLINE: 9509448]
106. Schrander-vd Meer AM, ter Wee PM, Donker AJ, van Dorp WT. Improved dialysis efficiency during acetate free biofiltration [abstract]. Nephrology 1997;3(Suppl 1):S538. [CENTRAL: CN-00461692]
107. Schrander-vd Meer AM, ter Wee PM, Kan G, Donker AJ, van Dorp WT. Cardiovascular effects of acetate free biofiltration [abstract]. Journal of the American Society of Nephrology 1997;8(Program & Abstracts):172A. [CENTRAL: CN-00447637]
108. Schrander-vd Meer AM, ter Wee PM, Kan G, Donker AJ, van Dorp WT. Improved cardiovascular variables during acetate free biofiltration. Clinical Nephrology 1999;51(5):304-9. [MEDLINE: 10363631]
109. Selby NM, Fluck RJ, Taal MW, McIntyre CW. Acetate-free double chamber haemodiafiltration (PHF) is associated with improved systemic haemodynamics and lower troponin-T levels as compared with standard dialysis [abstract no: SP298]. Nephrology Dialysis Transplantation 2005;20(Suppl 5):v119.
110. Selby NM, Fluck RJ, Taal MW, McIntyre CW. Effects of acetate-free double-chamber hemodiafiltration and standard dialysis on systemic hemodynamics and troponin T levels. ASAIO Journal 2006;52(1):62-9. [MEDLINE: 16436892]
111. Stefansson BV, Abramson M, Nilsson U, Haraldsson B. Hemodiafiltration improves plasma 25-hepcidin levels: a prospective, randomized, blinded, cross-over study comparing hemodialysis and hemodiafiltration. Nephron Extra 2012;2(1):55-65. [MEDLINE: 22619668]
112. Stefansson BV, Haraldsson B. A prospective, double blinded, randomized, cross-over study comparing hemodialysis and hemodiafiltration regarding dialysis complications, quality of life and non-traditional cardiovascular risk factors [abstract no: TH-PO626]. Journal of the American Society of Nephrology 2008;19(Abstracts Issue):248A.
113. Teo KK, Basile C, Ulan RA, Hetherington MD, Kappagoda T. Effects of hemodialysis and hypertonic hemodiafiltration on cardiac function compared. Kidney International 1987;32(3):399-407. [EMBASE: 1987215388]
114. Todeschini M, Macconi D, Fernandez NG, Ghilardi M, Anabaya A, Binda E, et al. Effect of acetate-free biofiltration and bicarbonate hemodialysis on neutrophil activation. American Journal of Kidney Diseases 2002;40(4):783-93. [MEDLINE: 12324914]
115. Tuccillo S, Bellizzi V, Catapano F, Di Iorio B, Esposito L, Giannattasio P, et al. Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels [Effetti acuti e cronici della emodialisi standard e dell'emodiafiltrazione-soft sui livelli interdialitici della fosforemia]. Giornale Italiano di Nefrologia 2002;19(4):439-45. [MEDLINE: 12369047]
116. Keller DM. Hemodiafiltration, hemodialysis show similar survival rates. 2011. http://www.medscape.com/viewarticle/746131 (accessed 26 March 2015).
117. Ok E, Asci G, Ok ES, Kircelli F, Yilmaz M, Demirci MS, et al. Comparison of post dilution on-line hemodiafiltration and hemodialysis (Turkish HDF study) [abstract]. NDT Plus 2011;4(Suppl 2):4.2S.1.
118. Ok E, Asci G, Toz H, Ok ES, Kircelli F, Yilmaz M, et al. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study. Nephrology Dialysis Transplantation 2013;28(1):192-202. [MEDLINE: 23229932]
119. Vaslaki L, Berta K, Ladanyi E, Pethoe F, Karatson A, Misz M, et al. Less need for erythropoietin in on-line haemodiafiltration compared to haemodialysis [abstract no: MP406]. Nephrology Dialysis Transplantation 2005;20(Suppl 5):v336.
120. Vaslaki L, Major L, Berta K, Karatson A, Misz M, Pethoe F, et al. On-line haemodiafiltration versus haemodialysis: stable haematocrit with less erythropoietin and improvement of other relevant blood parameters. Blood Purification 2006;24(2):163-73. [MEDLINE: 16352871]
121. Verzetti G, Navino C, Bolzani R, Galli G, Panzetta G. Acetate-free biofiltration versus bicarbonate haemodialysis in the treatment of patients with diabetic nephropathy: a cross-over multicentric study. Nephrology Dialysis Transplantation 1998;13(4):955-61. [MEDLINE: 9568857]
122. Verzetti G, Navino C, Panzetta G, Galli G, Ortensia A, Odone P, et al. Multicentric trial on acetate-free biofiltration (AFB) and diabetes [abstract]. Nephrology Dialysis Transplantation 1995;10(6):1031. [CENTRAL: CN-00261128]
123. Ward RA, Schmidt B, Hillebrand GF, Samtleben W. On-line hemodiafiltration (HDF) provides better solute removal than high-flux hemodialysis (hfHD) [abstract]. Journal of the American Society of Nephrology 1998;9(Program & Abstracts):186A. [CENTRAL: CN-00448283]
124. Ward RA, Schmidt B, Hullin J, Hillebrand GF, Samtleben W. A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. Journal of the American Society of Nephrology 2000;11(12):2344-50. [MEDLINE: 11095657]
125. Wizemann V, Lotz C, Techert F, Uthoff S. On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study. Nephrology Dialysis Transplantation 2000;15 Suppl 1:43-8. [MEDLINE: 10737166]
126. Adam S, Gretz N, Hafner G, Ragaller M, Abreu M, Bender HJ. Influence of haemofiltration, -diafiltration and -dialysis on the elimination of urophanic substances under continuous renal-replacement-therapy with high-reflux-membranes [abstract]. Wiener Klinische Wochenschrift 1996;108(Suppl 1):28. [CENTRAL: CN-00251993]
127. Ahrenholz P, Winkler RE, et al. On-line hemodiafiltration with pre- and post-dilution: a comparison of efficacy and compatibility [abstract]. Nephrology Dialysis Transplantation 1997;12(9):A125. [CENTRAL: CN-00261396]
128. Ahrenholz P, Winkler RE, Ramlow W, Tiess M, Thews O. On-line hemodiafiltration with pre- and postdilution: impact on the acid-base status. International Journal of Artificial Organs 1998;21(6):321-7. [MEDLINE: 9714025]
129. Ahrenholz PG, Winkler RE, Michelsen A, Lang DA, Bowry SK. Dialysis membrane-dependent removal of middle molecules during hemodiafiltration: the beta2-microglobulin/albumin relationship. Clinical Nephrology 2004;62(1):21-8. [MEDLINE: 15267009]
130. Altieri P, Sorba GB, Bolasco PG, Bostrom M, Asproni E, Ferrara R, et al. On-line predilution hemofiltration versus ultrapure high-flux hemodialysis: a multicenter prospective study in 23 patients. Sardinian Collaborative Study Group of On-Line Hemofiltration. Blood Purification 1997;15(3):169-81. [MEDLINE: 9262843]
131. Altieri P, Sorba GB, Bolasco PG, Ledebo I, Asproni E, Ferrara R, et al. Predilution hemofiltration vs hemodialysis. Results from prospective crossover multicenter study [abstract]. Nephrology Dialysis Transplantation 1999;14(9):A224. [CENTRAL: CN-00520313]
132. Altieri P, Sorba G, Bolasco P, Asproni E, Ledebo I, Bostrom M, et al. Pre-dilution haemofiltration--the Sardinian multicentre studies: Present and future. The Sardinian Collaborative Study Group on Haemofiltration On-Line. Nephrology Dialysis Transplantation 2000;15 Suppl 2:55-9. [MEDLINE: 11051039]
133. Altieri P, Sorba G, Bolasco P, Asproni E, Ledebo I, Cossu M, et al. Predilution haemofiltration--the Second Sardinian Multicentre Study: comparisons between haemofiltration and haemodialysis during identical Kt/V and session times in a long-term cross-over study. Nephrology Dialysis Transplantation 2001;16(6):1207-13. [MEDLINE: 11390722]
134. Baldamus CA, Knobloch M, Schoeppe, Koch KM. Hemodialysis/hemofiltration: a report of a controlled cross-over study. International Journal of Artificial Organs 1980;3(4):211-4. [MEDLINE: 6997218]
135. Baldamus CA, Ernst W, Frei U, Koch KM. Sympathetic and hemodynamic response to volume removal during different forms of renal replacement therapy. Nephron 1982;31(4):324-32. [MEDLINE: 7177269]
136. Baldamus CA, Quellhorst E. Outcome of long-term hemofiltration. Kidney International - Supplement 1987;17:S41-6. [MEDLINE: 3912587]
137. Baragett I, Bamonti F, Patrosso C, Corghi E, Furiani S, D'Aloja G, et al. Effect of acetate free biofiltration on hyperhomocysteinemia in uremic patients: A cross-sectional multicenter study. International Journal of Artificial Organs 2003;26(3):256-8. [MEDLINE: 12703894]
138. Basile C, Di Maggio A, Scatizzi A. Acid-base imbalance correction and dialysis hypoxemia in hypertonic hemodiafiltration (HHDF) [abstract]. Kidney International 1985;28(2):364. [CENTRAL: CN-00550391]
139. Basile C, Di Maggio A, Scatizzi A. Small and middle molecules removal in hypertonic hemodiafiltration [abstract]. Kidney International 1985;28(2):364. [CENTRAL: CN-00550396]
140. Basile C, Miller JD, Koles ZJ, Grace M, Ulan RA. The effects of dialysis on brain water and EEG in stable chronic uremia. American Journal of Kidney Diseases 1987;9(6):462-9. [MEDLINE: 3591793]
141. Basile C, Di Maggio A, Ulan RA, Scatizzi A. Hypertonic hemodiafiltration: a preliminary report on a cross-over study. Kidney International - Supplement 1988;24:S132-4. [MEDLINE: 3163033]
142. Bazzato G, Coli U, Landini S, Fracasso A, Righetto F, Scanferla F, et al. Removal of phosphate either by bicarbonate dialysis or biofiltration in uremics. Kidney International - Supplement 1988;24:S180-3. [MEDLINE: 3163046]
143. Beerenhout CH, Kooman JP, Luik AJ, Jeuken-Mertens SG, Van Der Sande FM, Leunissen KM. Optimizing renal replacement therapy--a case for online filtration therapies?. Nephrology Dialysis Transplantation 2002;17(12):2065-70. [MEDLINE: 12454212]
144. Bolasco P, Altieri P, Sorba G, Cabiddu G, Ferrara R, Serra G, et al. Adequacy in pre-dilution haemofiltration: Kt/V or infusion volume? The Sardinian Collaborative Study Group on Haemofiltration On-line. Nephrology Dialysis Transplantation 2000;15 Suppl 2:60-4. [MEDLINE: 11051040]
145. Bonaudo R, Pacitti A, Amore A, Gianoglio B, Perugin L, Goldoni M, et al. Hemofiltration without heparin [abstract]. Journal of the American Society of Nephrology 1998;9(Program & Abstracts):167A. [CENTRAL: CN-00444479]
146. Bonomini M, Ballone E, Di Stante S, Bucciarelli T, Dottori S, Arduini A, et al. Removal of uraemic plasma factor(s) using different dialysis modalities reduces phosphatidylserine exposure in red blood cells. Nephrology Dialysis Transplantation 2004;19(1):68-74. [MEDLINE: 14671041]
147. Bordin V, Catalano C, Berto A, Silvestrin G, Di Landro D, Fabbian F. Determining the prescription for online predilution hemofiltration: Our experience and a review of the literature. Dialysis & Transplantation 2002;31(6):375-9. [EMBASE: 2002191148]
148. Bosc JY, LeBlanc M, et al. Comparison between high flux cellulose triacetate and high flux polysulfone: a clinical study in hemodialysis and hemodiafiltration [abstract]. Nephrology Dialysis Transplantation 1997;12(9):A150. [CENTRAL: CN-00261407]
149. Bosc JY, LeBlanc M, Garred LJ, Marc JM, Foret M, Babinet F, et al. Direct determination of blood recirculation rate in hemodialysis by a conductivity method. ASAIO Journal 1998;44(1):68-73. [MEDLINE: 9466504]
150. Bosticardo GM, Triolo G, Basolo B, Belardi P, Bossi P, Aprato A, et al. Hemofiltration: present and future [Emofiltrazione: presente e futuro]. Archivio Per Le Scienze Mediche 1981;138(1):1-10. [MEDLINE: 7247698]
151. Brink HS, Friemann AT, Huisman RM, de Jong PE. Acetate free biofiltration versus haemodiafiltration: a prospective cross-over trial [abstract]. Nephrology Dialysis Transplantation 1995;10(4):572. [CENTRAL: CN-00444541]
152. Calo L, Naso A, Carraro G, Wratten ML, Pagnin E, Bertipaglia L, et al. Effect of hemodiafiltration with on-line regeneration of ultrafiltrate (HFR) on oxidative stress in dialysis patients [abstract no: SP679]. Nephrology Dialysis Transplantation 2006;21(Suppl 4):iv244.
153. Calo LA, Naso A, Carraro G, Wratten ML, Pagnin E, Bertipaglia L, et al. Effect of haemodiafiltration with online regeneration of ultrafiltrate on oxidative stress in dialysis patients. Nephrology Dialysis Transplantation 2007;22(5):1413-9. [MEDLINE: 17237480]
154. Canaud B, Flavier JL, Argiles A, Stec F, NGuyen QV, Bouloux C, et al. Hemodiafiltration with on-line production of substitution fluid: long-term safety and quantitative assessment of efficacy. Contributions to Nephrology 1994;108:12-22. [MEDLINE: 8039393]
155. Canaud B, Bosc JY, Leray-Moragues H, Stec F, Argiles A, Leblanc M, et al. On-line haemodiafiltration. Safety and efficacy in long-term clinical practice. Nephrology Dialysis Transplantation 2000;15 Suppl 1:60-7. [MEDLINE: 10737169]
156. Canaud B, Wizemann V, Pizzarelli F, Greenwood R, Schultze G, Weber C, et al. Cellular interleukin-1 receptor antagonist production in patients receiving on-line haemodiafiltration therapy. Nephrology Dialysis Transplantation 2001;16(11):2181-7. [MEDLINE: 11682665]
157. Cappelli G, Icardi A, Lamperi S. Biofiltration (BF) versus hemofiltration (HF) in the treatment of chronic uremia [abstract]. Kidney International 1985;28(2):365. [CENTRAL: CN-00550380]
158. Carozzi S, Nasini MG, Caviglia PM, Schelotto C, Santoni O, Atti M. Acetate free biofiltration. Effects on peripheral blood monocyte activation and cytokine release. ASAIO Journal 1992;38(1):52-4. [MEDLINE: 1313318]
159. Cavalcanti S, Ciandrini A, Severi S, Badiali F, Bini S, Gattiani A, et al. Model-based study of the effects of the hemodialysis technique on the compensatory response to hypovolemia. Kidney International 2004;65(4):1499-510. [MEDLINE: 15086494]
160. Cerulli N, La Greca G, Laville M, Palla R, Ramello A, Ghezzi PM, et al. The effect of hemodiafiltration with on-line endogenous reinfusion (on-line HFR) on anemia: Design of a European, open, randomised, multicentre trial. European Collaborative Study. Journal of Nephrology 2000;13(1):34-42. [MEDLINE: 10720212]
161. Champagne K, Barre P, Tangri N, Iqbal S, Kimoff RJ. Effect of hemodiafiltration vs conventional hemodialysis on sleep apnea severity and 24-hour blood pressure level [abstract no: M545]. World Congress of Nephrology; 2009 May 22-26; Milan, Italy. 2009.
162. Champagne K, Tangri N, Barre P, Kimoff R. Effect of hemodiafiltration (HDF) vs. conventional hemodialysis (CHD) on sleep apnea (SA) severity: findings of a pilot randomized cross-over study [abstract no: J14]. American Thoracic Society International Conference; 2008 May 16-21; Toronto, Canada. 2008:A937.
163. Chanard J, Toupance O, Gillery P, Lavaud S. Evaluation of protein loss during hemofiltration. Kidney International - Supplement 1988;24:S114-6. [MEDLINE: 3163030]
164. Chang TM, Chirito E, Barre P, Cole C, Lister C, Resurreccion E. Long-term clinical assessment of combined ACAC hemoperfusion-ultrafiltration in uremia. Artificial Organs 1979;3(2):127-31. [MEDLINE: 533395]
165. Chauveau P, Houillier P, Ramdane M, Zins B, Poignet JL, Naret C, et al. Serial determinations of bone mineral density in hemodialyzed patients on acetate free biofiltration [abstract]. 12th International Congress of Nephrology; 1993 Jun 13-18; Jerusalem, Israel. 1993:468.
166. Chen X, Li Z, Wu P, Zhang D, Shen Q, Yu X. B2-microglobulin and iPTH removal in on-line hemodiafiltration versus low- and high-flux hemodialysis [abstract no: T-PO40041]. Nephrology 2005;10(Suppl 1):A185. [CENTRAL: CN-00782409]
167. Chiappini MG, Ammann T, Selvaggi G, Bravi M, Traietti P. Effects of different dialysis membranes and techniques on the nutritional status, morbidity and mortality of hemodialysis patients [Effetti di diverse membrane e metodiche dialitiche sullo stato nutrizionale, morbilita e mortalita di pazienti emodializzati]. Giornale Italiano di Nefrologia 2004;21 Suppl 30:S190-6. [MEDLINE: 15750983]
168. Cirillo I, Vaccaro N, Balis D, Redman R, Matzke GR. Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenem. Antimicrobial Agents & Chemotherapy 2011;55(3):1187-93. [MEDLINE: 21199922]
169. Collins AJ, Keshaviah P, Ilstrup KM, Shapiro F. Clinical comparison of hemodialysis and hemofiltration. Kidney International - Supplement 1985;17:S18-22. [MEDLINE: 3867792]
170. David S, Triolo G, Tessitore N, Gruppo di Studio Collaborativo Europeo HFR on line. EPO response in patients treated by hemodiafiltration with infusion of regenerated ultrafiltrate (on line HFR): a protocol for a multicenter study [abstract]. Nephrology Dialysis Transplantation 2000;15(9):A163. [CENTRAL: CN-00460611]
171. Duranti E. Acetate-free hemodialysis: a feasibility study on a technical alternative to bicarbonate dialysis. Blood Purification 2004;22(5):446-52. [MEDLINE: 15365213]
172. Feliciani A, Riva MA, Zerbi S, Ruggiero P, Plati AR, Cozzi G, et al. New strategies in haemodiafiltration (HDF): prospective comparative analysis between on-line mixed HDF and mid-dilution HDF. Nephrology Dialysis Transplantation 2007;22(6):1672-9. [MEDLINE: 17347283]
173. Pedrini LA, Feliciani A, Riva A, Zerbi S, Cozzi G. Middle molecular uremic toxins removal. Prospective comparative study between two new on-line haemodiafiltration (HDF) techniques: mixed HDF and mid-dilution HDF [abstract no: SP695]. Nephrology Dialysis Transplantation 2006;21(Suppl 4):iv249. [CENTRAL: CN-00615864]
174. Fu R, Gui B, Wang L, Li R, Guo R, Zhang Y. The clinical study on dialysis effect and nutritional status of different dialysis modes. Journal of Xi'an Jiaotong University Medical Sciences 2006;27(4):414-6. [EMBASE: 2006447629]
175. Gerdemann A, Wagner Z, Solf A, Bahner U, Heidland A, Vienken J, et al. Plasma levels of advanced glycation end products during haemodialysis, haemodiafiltration and haemofiltration: Potential importance of dialysate quality. Nephrology Dialysis Transplantation 2002;17(6):1045-9. [MEDLINE: 12032195]
176. Giannattasio P, Minutolo R, Bellizzi V, Di Iorio BR, Scigliano R, Zamboli P, et al. Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound. American Journal of Kidney Diseases 2006;47(6):1045-54. [MEDLINE: 16731300]
177. Harzallah K, Hichri N, Mazigh C, Tagorti M, Hmida A, Hmida J. Variability of acid-base status in acetate-free biofiltration 84% versus bicarbonate dialysis. Saudi Journal of Kidney Diseases & Transplantation 2008;19(2):215-21. [MEDLINE: 18310870]
178. Hdez-Jaras J, Galan A, Martin J. Kinetics of bicarbonate and acetate: a comparative study between haemodiafiltration in double chamber and high-flow haemodialysis [abstract]. Nephrology Dialysis Transplantation 1994;9(10):1512. [CENTRAL: CN-00261075]
179. Henderson LW. Hemofiltration for the treatment of hypertensions associated with end-stage renal failure. Artificial Organs 1980;4(2):103-7. [MEDLINE: 6994698]
180. Higuchi T, Yamamoto C, Kuno T, Okada K, Soma M, Fukuda N, et al. A comparison of bicarbonate hemodialysis, hemodiafiltration, and acetate-free biofiltration on cytokine production. Therapeutic Apheresis & Dialysis 2004;8(6):460-7. [MEDLINE: 15663545]
181. Hillion D, Robine M, et al. Evaluation of a new triacetate membrane in hemodiafiltration (HDF) compared with 5 high performance hemodiafilters [abstract]. Nephrology Dialysis Transplantation 1997;12(9):A167. [CENTRAL: CN-00261415]
182. Hmida J, Balma A, Lebben I, Hichri N, Dhahri M. Clinical evaluation of acetate-free biofiltration at 84 0/00 in patients with chronic renal insufficiency [Evaluation clinique a moyen terme de la technique de biofiltration sans acetate a 84 0/00 chez les malades insuffisants renaux chroniques]. Tunisie Medicale 2002;80(8):473-84. [MEDLINE: 12703128]
183. Ikebe N, Eguchi K, Suzuki K, Miwa N, Mineshima M, Akiba T. Trial of a new haemodiafiltration (HDF): intermittent infusion HDF [abstract no: SP685]. Nephrology Dialysis Transplantation 2006;21(Suppl 4):iv246.
184. Jahn H, Schohn D, Schmitt R. Hemodynamic studies in chronic terminal renal insufficiency--Effects of hemodialysis (Hd), hemofiltration (Hf) and ultrafiltration (Uf) procedures [Etudes hemodynamiques au cours de l'insuffisance renale chronique terminale--effets des techniques d'epuration extrarenale]. Nephrologie 1981;2(2):53-62. [MEDLINE: 7290301]
185. Jose M, Yu R, Kirkland G. The influence of haemodiafiltration on inflammation, insulin resistance and adipokines [abstract no: 044]. Nephrology 2008;13(Suppl 3):A110.
186. Joyeux V, Sijpkens Y, Nilsson L, Haddj-Elmrabet A, Bijvoet AJ. Automated pressure control mode improves middle molecule removal in hemodiafiltration [abstract no: M450]. World Congress of Nephrology; 2009 May 22-26; Milan, Italy. 2009.
187. Kanter J, Puerta MC, Garcia RP, Gomez JM, Jofre R, Rodriguez PB. On-line sequential hemodiafiltration (HDF-OL-S): a new therapeutic option [Hemodiafiltracion en linea secuencial (HDF-OL-S): una nueva opcion terapeutica]. Nefrologia 2008;28(4):433-8. [MEDLINE: 18662152]
188. Katschnig H, Pogglitsch H, Holzer H. Hemofiltrate dialysis: first experiences with hemofiltrate regeneration by means of dialysis [Hamofiltratdialyse: klinisch-experimentelle daten zur hamofiltratregeneration mittels dialyse]. Nieren-und Hochdruckkrankheiten 1980;9(3):132-5. [EMBASE: 1980220746]
189. Kim S, Oh KH, Chin HJ, Na KY, Kim YS, Chae DW, et al. Effective removal of leptin via hemodiafiltration with on-line endogenous reinfusion therapy. Clinical Nephrology 2009;72(6):442-8. [MEDLINE: 19954721]
190. Kishimoto T, Yamagami S, Tanaka H, Ohyama T, Yamamoto T, Yamakawa M, et al. Superiority of hemofiltration to hemodialysis for treatment of chronic renal failure: comparative studies between hemofiltration and hemodialysis on dialysis disequilibrium syndrome. Artificial Organs 1980;4(2):86-93. [MEDLINE: 7396769]
191. Klemm A, Sperschneider H, Winnefeld K, Gunther K, Stein G. Comparison of aluminum removal between hemodialysis with polycarbonate low flux membrane and hemofiltration with polysulfone high flux membrane in end-stage renal failure patients. Clinical Nephrology 1997;47(2):133-4. [MEDLINE: 9049466]
192. Klingel R, Schaefer M, Schwarting A, Himmelsbach F, Altes U, Uhlenbusch-Korwer I, et al. Comparative analysis of procoagulatory activity of haemodialysis, haemofiltration and haemodiafiltration with a polysulfone membrane (APS) and with different modes of enoxaparin anticoagulation. Nephrology Dialysis Transplantation 2004;19(1):164-70. [MEDLINE: 14671052]
193. Krieter DH, Falkenhain S, Chalabi L, Collins G, Lemke HD, Canaud B. Clinical cross-over comparison of mid-dilution hemodiafiltration using a novel dialyzer concept and post-dilution hemodiafiltration. Kidney International 2005;67(1):349-56. [MEDLINE: 15610261]
194. Krieter DH, Falkenhain S, Chalabi L, Collins G, Summerton J, Spence E, et al. Improved middle molecule removal in mid-dilution HDF (HDF) with the nephros olpur™ md 190 filter compared to post-dilution HDF (post-HDF) [abstract]. 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:366. [: CN-00509293]
195. Krieter DH, Hunn E, Morgenroth A, Lemke HD, Wanner C. Matching efficacy of high-efficiency HDF in simple HD mode with PUREMA [abstract no: PUB297]. Journal of the American Society of Nephrology 2007;18(Abstracts Issue):894A.
196. Krieter DH, Hunn E, Morgenroth A, Lemke HD, Wanner C. Matching efficacy of online hemodiafiltration in simple hemodialysis mode. Artificial Organs 2008;32(12):903-9. [MEDLINE: 19133017]
197. Krieter DH, Hackl A, Rodriguez A, Chenine L, Moragues HL, Lemke HD, et al. Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration. Nephrology Dialysis Transplantation 2010;25(1):212-8. [MEDLINE: 19755476]
198. Kuno T, Kikuchi F, Yanai M, Nagura Y, Takahashi S. Clinical advantages of acetate-free biofiltration. Contributions to Nephrology 1994;108:121-30. [MEDLINE: 8039394]
199. Leber HW, Wizemann V, Techert F. Simultaneous hemofiltration/hemodialysis (HF/HD): short- and long-term tolerance. Introduction of a system for automatic fluid replacement. Artificial Organs 1980;4(2):108-12. [MEDLINE: 7396762]
200. Li X, Li M, Liu T, Li L, Duan L, Li Y, et al. Hemofiltration or hemodiafiltration with on-line production of substitution fluid: clinical observation of safety and effectiveness. Chinese Medical Journal 1997;110(7):520-5. [MEDLINE: 9594209]
201. Lin CL, Huang CC, Yu CC, Yang HY, Chuang FR, Yang CW. Reduction of advanced glycation end product levels by on-line hemodiafiltration in long-term hemodialysis patients. American Journal of Kidney Diseases 2003;42(3):524-31. [MEDLINE: 12955680]
202. Liomin E, Schneider H, Streicher E. Hemodynamics during hemodialysis, hemofiltration and hemodiafiltration using bicarbonate vs acetate buffers [Hamodynamik bei hamodialyse, hamofiltration und hamodiafiltration bikarbonat-vs azetatpufferung]. Klinische Wochenschrift 1984;62(19):911-9. [MEDLINE: 6503213]
203. Locatelli F, Del Vecchio L, Manzoni C. Morbidity and mortality on maintenance haemodialysis. Nephron 1998;80(4):380-400. [MEDLINE: 9832637]
204. Locatelli F, Marcelli D, Conte F, Limido A, Malberti F, Spotti D. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. The Registro Lombardo Dialisi E Trapianto. Kidney International 1999;55(1):289-93. [MEDLINE: 9893138]
205. Locatelli F, Del Vecchio L, Andrulli S. Dialysis: its role in optimizing recombinant erythropoietin treatment. Nephrology Dialysis Transplantation 2001;16 Suppl 7:29-35. [MEDLINE: 11590254]
206. Locatelli F, Manzoni C, Di Filippo S. The importance of convective transport. Kidney International - Supplement 2002;80:115-20. [MEDLINE: 11982825]
207. Lornoy W, Becaus I, Billiouw JM, Sierens L, Van Malderen P, Van Rampelbergh S, et al. B2 microglobulin kinetics in on-line hemodiafiltration with high volume of replacement solution versus high flux hemodialysis. Is there a limit in the amount of replacement volume? [abstract]. 35th Congress. European Renal Association. European Dialysis and Transplantation Association; 1998 Jun 6-9; Rimini, Italy. 1998:302. [CENTRAL: CN-00484891]
208. Lornoy W, Becaus I, Billiouw J, Beckers F, Van Malderen P, Van Langenhove P. Comparison of different high flux membranes with on-line hemodialfiltration [abstract]. Journal of the American Society of Nephrology 2001;12(Program & Abstracts):453A. [CENTRAL: CN-00626021]
209. Lornoy W, Becaus I, Billiouw JM, Beckers F, Van Malderen P, Van Langenhove P. Comparison of different high flux membranes with on-line haemodiafiltration (HDF) [abstract]. 38th Congress. European Renal Association. European Dialysis and Transplantation Association; 2001 Jun 24-27; Vienna, Austria. 2001:253. [CENTRAL: CN-00461209]
210. Maeda K, Kobayakawa H, Fujita Y, Takai I, Morita H, Emoto Y, et al. Effectiveness of push/pull hemodiafiltration using large-pore membrane for shoulder joint pain in long-term dialysis patients. Artificial Organs 1990;14(5):321-7. [MEDLINE: 2241598]
211. Maggiore Q, Pizzarelli F, Dattolo P, Maggiore U, Cerrai T. Cardiovascular stability during haemodialysis, haemofiltration and haemodiafiltration. Nephrology Dialysis Transplantation 2000;15 Suppl 1:68-73. [MEDLINE: 10737170]
212. Maheshwari V, Samavedham L, Rangaiah GP, Loy Y, Ling LH, Sethi S, et al. Comparison of toxin removal outcomes in online hemodiafiltration and intra-dialytic exercise in high-flux hemodialysis: a prospective randomized open-label clinical study protocol. BMC Nephrology 2012;13:156. [MEDLINE: 23176731]
213. Malberti F, Surian M, Farina M, Vitelli E, Mandolfo S, Guri L, et al. Effect of hemodialysis and hemodiafiltration on uremic neuropathy. Blood Purification 1991;9(5-6):285-95. [MEDLINE: 1668062]
214. Mastrangelo F, Rizzelli S, Passione A, Procaccini DA, Gigante B, Gallucci M, et al. Puglia cooperative study on biofiltration. International Journal of Artificial Organs 1986;9 Suppl 3:25-6. [MEDLINE: 3557668]
215. Mesic E, Bock A, Major L, Vaslaki L, Berta K, Wikstrom B, et al. Dialysate saving by automated control of flow rates: comparison between individualized online hemodiafiltration and standard hemodialysis. Hemodialysis International 2011;15(4):522-9. [MEDLINE: 22111821]
216. Minutolo R, Bellizzi V, Cioffi M, Iodice C, Giannattasio P, Andreucci M, et al. Postdialytic rebound of serum phosphorus: pathogenetic and clinical insights. Journal of the American Society of Nephrology 2002;13(4):1046-54. [MEDLINE: 11912265]
217. Mioli V, Albertazzi A, Baroni C, Bordoni E, Buoncristiani U, Capponi E, et al. Polycentric 384-month study of biofiltration (BF) with AN69s. International Journal of Artificial Organs 1986;9 Suppl 3:15-6. [MEDLINE: 3549572]
218. Mishkin MA, Mishkin GJ, Lew SQ. Solute removal in hemodiafiltration compared to standard high flux dialysis: combined analysis of 2 cross over studies [abstract no: F-P0870]. Journal of the American Society of Nephrology 2002;13(September, Program & Abstracts):238A. [CENTRAL: CN-00446789]
219. Mohini R, Michaels R, Trost C, Gron D, Zasuwa G, Dumler F, et al. Comparison of effect of recombinant human erythropoietin (rHEPO) in patients on high flux (HF) vs conventional (C) hemodialysis [abstract]. Kidney International 1989;35(1):256. [CENTRAL: CN-00782715]
220. Morena M, Dupuy A, Taamma R, Tetta C, Cristol J, Canaud B, et al. Convective techniques improve middle substances removal: a randomized cross-over study comparing hemodialysis and on line hemodiafiltration using HF80 versus FX80 [abstract no: SP697]. Nephrology Dialysis Transplantation 2006;21(Suppl 4):iv251.
221. Movilli E, Camerini C, Gaggia P, Poiatti P, Pola A, Viola BF, et al. Effect of post-dilutional on-line haemodiafiltration on serum calcium, phosphate and parathyroid hormone concentrations in uraemic patients. Nephrology Dialysis Transplantation 2011;26(12):4032-7. [MEDLINE: 21555393]
222. Kuchle C, Fricke H, Held E, Schiffl H. High-flux hemodialysis postpones clinical manifestation of dialysis-related amyloidosis. American Journal of Nephrology 1996;16(6):484-8. [MEDLINE: 8955759]
223. Kuchle C, Fricke H, et al. High-flux hemodialysis postpones clinical manifestation of dialysis associated amyloidosis [abstract]. Nephrology Dialysis Transplantation 1996;11(6):A232. [: CN-00261301]
224. Kuchle C, Lang SM, Held E, Schiffl H. Biocompatibility, b2-microglobulin and dialysis-associated amyloidosis [abstract]. Nephrology 1997;3(Suppl 1):S404. [CENTRAL: CN-00461113]
225. Mrowka C, Schiffl H. Comparative evaluation of beta 2-microglobulin removal by different hemodialysis membranes: a six-year follow-up. Nephron 1993;63(3):368-9. [MEDLINE: 8446285]
226. Schiffl H, Kuchle C, Held E. Beta-2-microglobulin removal by different hemodialysis membranes. Contributions to Nephrology 1995;112:156-63. [MEDLINE: 7554987]
227. Nakazawa R, Nakamura M, et al. A comparison of b2-microglobulin removal during haemodialysis, haemodiafiltration and direct haemoperfusion [abstract]. Nephrology Dialysis Transplantation 1997;12(9):A175. [CENTRAL: CN-00261422]
228. Ohyama T. Study on guanidine compounds in chronic renal failure: comparison of hemofiltration (HF) and hemodialysis (HD). Journal of the Osaka City Medical Center 1981;30(3):533-43. [EMBASE: 1982218680]
229. Pacitti A, Tetta C, Mangiarotti G, Canavese C, Segoloni GP. Beta-2-microglobulin serum profiles in different settings of mass transport and fluid pyrogen content. Kidney International - Supplement 1993;41:S96-9. [MEDLINE: 8320955]
230. Panichi V, Parrini M, Bianchi AM, Andreini B, Cirami C, Finato V, et al. Mechanisms of acid-base homeostasis in acetate and bicarbonate dialysis, lactate hemofiltration and hemodiafiltration. International Journal of Artificial Organs 1994;17(6):315-21. [MEDLINE: 7806416]
231. Panichi V, De Pietro S, Andreini B, Migliori M, Tessore V, Taccola D, et al. Cytokine production in haemodiafiltration: a multicentre study. Nephrology Dialysis Transplantation 1998;13(7):1737-44. [MEDLINE: 9681721]
232. Panichi V, Manca-Rizza G, Paoletti S, Filippi C, Consani C, Sidoti A, et al. Effects of inflammatory and nutritional markers of hemodiafiltration with online regeneration of ultrafiltrate (HFR) versus on-line hemodiafiltration: a cross-over randomized multicenter trial [abstract no: MO13]. Nephrology Dialysis Transplantation 2005;20(Suppl 5):v191.
233. Panichi V, Manca-Rizza G, Paoletti S, Taccola D, Consani C, Filippi C, et al. Effects on inflammatory and nutritional markers of haemodiafiltration with online regeneration of ultrafiltrate (HFR) vs online haemodiafiltration: a cross-over randomized multicentre trial. Nephrology Dialysis Transplantation 2006;21(3):756-62. [MEDLINE: 16303780]
234. Pedrini L, De Cristafaro V. Hemodiafiltration with simultaneous pre and post dilution (pre-post-HDF) [abstract]. Nephrology Dialysis Transplantation 1999;14(9):A177. [CENTRAL: CN-00583434]
235. Pedrini LA, Cozzi G, Faranna P, Mercieri A, Ruggiero P, Zerbi S, et al. Transmembrane pressure modulation in high-volume mixed hemodiafiltration to optimize efficiency and minimize protein loss. Kidney International 2006;69(3):573-9. [MEDLINE: 16407883]
236. Feliciani A. Reverse mid-dilution HDF: technical optimization for clearance optimization [abstract no: SP255]. XLV ERA-EDTA Congress; 2008 May 10-13; Stockholm, Sweden. 2008.
237. Pedrini LA, Feliciani A, Zerbi S, Cozzi G, Ruggiero P. Optimization of mid-dilution haemodiafiltration: technique and performance. Nephrology Dialysis Transplantation 2009;24(9):2816-24. [MEDLINE: 19420103]
238. Pedrini LA, Gmerek A, Wagner J. Efficiency of post-dilution hemodiafiltration with a high-flux alpha-polysulfone dialyzer. International Journal of Artificial Organs 2011;34(5):397-404. [MEDLINE: 21574157]
239. Petras D, Fortunato A, Soffiati G, Brendolan A, Bonello M, Crepaldi C, et al. Sequential convective therapies (SCT): a prospective study on feasibility, safety, adequacy and tolerance of on-line hemofiltration and hemodiafiltration in sequence. International Journal of Artificial Organs 2005;28(5):482-8. [EMBASE: 2005265716]
240. Pizzarelli F, Cerrai T, Dattolo P, Ferro G. On-line haemodiafiltration with and without acetate. Nephrology Dialysis Transplantation 2006;21(6):1648-51. [MEDLINE: 16464887]
241. Pizzarelli F, Cerrai T, Ferro G, Dattolo P. On-line hemodiafiltration without acetate. Giornale Italiano di Nefrologia 2004;21 Suppl 30:S97-101. [MEDLINE: 15747315]
242. Quellhorst E. Long-term follow up in chronic hemofiltration. International Journal of Artificial Organs 1983;6(3):115-20. [MEDLINE: 6874123]
243. Quellhorst EA, Schuenemann B, Hildebrand U. Morbidity and mortality in long-term hemofiltration. ASAIO Journal 1983;6(4):185-91. [EMBASE: 1984102779]
244. Ragazzoni E, Carpani P, Agliata S, Ciranna G, Cusinato S, Albini M, et al. HFR vs HDF-ON line: plasmatic amino acids loss evaluation [HFR vs HDF on-line: valutazione della perdita aminoacidica plasmatica]. Giornale Italiano di Nefrologia 2004;21 Suppl 30:S85-90. [MEDLINE: 15747313]
245. Ramunni A, Piccolo T, Saracino A, Di Bitonto G, Coratelli P. Efficacy of hemodiafiltration with endogenous reinfusion (HFR) in reducing amino acids depletion: comparison with bicarbonate dialysis [abstract no: SP693]. Nephrology Dialysis Transplantation 2006;21(Suppl 4):iv249.
246. Rius A, Hernandez-Jaras J, Pons R, Garcia Perez H, Torregrosa E, Sanchez Canel JJ, et al. Kinetic of calcium, phosphate, magnesium and PTH variations during hemodiafiltration [Cineica del calcio, fosforo, magnesio y variaciones de la parathormona (PTH) en pacientes en hemodiafiltracion]. Nefrologia 2007;27(5):593-8. [MEDLINE: 18045035]
247. Ronco C, Brendolan A, Milan M, Rodeghiero MP, Zanella M, La Greca G. Impact of biofeedback-induced cardiovascular stability on hemodialysis tolerance and efficiency. Kidney International 2000;58(2):800-8. [MEDLINE: 10916105]
248. Sakurai S, Yoshiyama N, Takeuchi H. Acetate-free biofiltration (AFBF) vs. bicarbonate hemodialysis (BHD): evaluation of short-time AFBF with various doses of hypertonic bicarbonate solution [abstract]. 11th International Congress of Nephrology; 1990 Jul 15-20; Tokyo, Japan. 1990:20A.
249. Ferramosca E, Conz P, De Cristofaro V, Gaggi R, Grammatico F, Wratten ML, et al. Mid-dilution hemodiafiltration: a new technique able to maximize the middle molecules removal [abstract no: TH-PO640]. Journal of the American Society of Nephrology 2005;16:258A. [CENTRAL: CN-00644157]
250. Santoro A, Conz PA, De C, Acquistapace I, Gaggi R, Ferramosca E, et al. Mid-dilution: the perfect balance between convection and diffusion. Contributions to Nephrology 2005;149:107-14. [MEDLINE: 15876834]
251. Santoro A, London G, Cagnoli L, Mercadal L, Fessy H, Perrone B, et al. Intra-dialytic potassium (K+) profiling may reduce the risk of cardiac arrhytmias in hemodialysi (HD) patients [abstract no: FP353]. Nephrology Dialysis Transplantation 2007;22(Suppl 6):vi136. [CENTRAL: CN-00644249]
252. Santoro A, Mancini E, London G, Mercadal L, Fessy H, Perrone B, et al. Patients with complex arrhythmias during and after haemodialysis suffer from different regimens of potassium removal. Nephrology Dialysis Transplantation 2008;23(4):1415-21. [MEDLINE: 18065796]
253. Savoldi S, Sereni L, Bertok S, Ianche M, Bianco F, Marega A, et al. The hemodiafiltration with infusion of acetate-free dialysis fluid can modify the inflammatory response in patients "high responders" to inflammatory stimuli? [Il trattamento in emodiafiltrazione con infusione di liquido di dialisi (PHF acetate free) puo modificare la risposta infiammatoria in pazienti gia identificati come "high responders" a stimoli infiammatori?]. Giornale Italiano di Nefrologia 2004;21 Suppl 30:S122-7. [MEDLINE: 15747295]
254. Shaldon S, Beau MC, Claret G, Deschodt G, Oules R, Ramperez P, et al. Hemofiltration with regeneration of the ultrafiltrate by adsorption: preliminary clinical experience in the treatment of the terminal stage of chronic renal insufficiency [Homofiltration avec regeneration de l'ultrafiltrat par adsorption: premiere experience clinique chez l'insuffisant renal chronique au stade ultim]. Journal d Urologie et de Nephrologie 1978;84(12):878-83. [MEDLINE: 372555]
255. Sidoti A, Borracelli D, Biagioli M, Ghezzi PM. Bicarbonate balance in hemodiafiltration (HDF): a comparison between two infusion methods of on-line prepared solution [Bilancio dei bicarbonati in emodiafiltrazione (HDF): confronto fra due metodiche di reinfusione di liquido prodotto on-line]. Giornale Italiano di Nefrologia 2004;21 Suppl 30:S177-80. [MEDLINE: 15750980]
256. Sirolli V, Cappelli P, Amoroso L, Di Liberato L, Muscianese P, Brummer U, et al. Haemodiafiltration with on-line reinfusion of endogenous ultrafiltrate (HFR on-line) removes uraemic retained solutes causing increased exposure of phosphatidylserine on erythrocyte membrane [abstract]. 41st Congress. European Renal Association. European Dialysis and Transplantation Association; 2004 May 15-18; Lisbon, Portugal. 2004:383-4. [CENTRAL: CN-00509484]
257. Sirolli V, Cappelli P, Amoroso L, Di Liberato L, Muscianese P, Santarelli P, et al. On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane [HFR on-line e rimozione di tossine uremiche inducenti la perdita dell'asimmetria fosfolipidica della membrana eritrocitaria]. Giornale Italiano di Nefrologia 2004;21 Suppl 30:S208-11. [MEDLINE: 15750987]
258. Spongano M, Santoro A, Bolzani R, Ferrari G, Aucella F, Borghi M, et al. Analysis of plasma bicarbonate determinants in acetate-free biofiltration [Analisi dei determinanti della bicarbonatemia post-dialitica in biofiltrazione senza acetato (AFB)]. Giornale Italiano di Nefrologia 1992;9(3):131-7. [EMBASE: 1992221794]
259. Strujic BJ, Vitunjski B, Majer L, Juric K, Crnjakovic J, Gudel J, et al. The effect of hemodiafiltration (HDF) and paired hemodiafiltration on-line (PHF) on the level of serum b2 microglobulin compared to conventional hemodialysis (HD) [abstract no: SP690]. Nephrology Dialysis Transplantation 2006;21(Suppl 4):iv248.
260. Susantitaphong P, Tiranathanagul K, Kanjanabuch T, Avihingsanon Y, Praditpornsilpa K, Tungsanga K, et al. Efficacy of mid-dilution on-line hemodiafiltration compared with two standard pre-dilution and post-dilution on-line hemodiafiltration [abstract no: THPO627]. Journal of the American Society of Nephrology 2008;19(Abstracts Issue):248A.
261. Timio M, Ronconi M, Venanzi S, Lazzaroni P, Lori G. Effect of biofiltration on cardiac arrhythmias. International Journal of Artificial Organs 1986;9 Suppl 3:129-32. [MEDLINE: 2435661]
262. Tomo T, Matsuyama K, Nasu M. Effect of hemodiafiltration against radical stress in the course of blood purification. Blood Purification 2004;22 Suppl 2:72-7. [MEDLINE: 15655328]
263. Umimoto K, Hirai Y, Hayashi T, Tanaka H. The effect of biofiltration on red blood cells 2.3-diphosphoglycerate and pH. Artificial Organs 2000;24(12):981-4. [MEDLINE: 11121979]
264. Vantelon J, Lauriat F, Perrone B, Jeannot F. Is it possible to treat uremia by hemofiltration? Initial clinical results obtained with a poly-acrylo-nytril membrane [Peut-on traiter l'uremie par hemofiltration? Premiers resultats cliniques obtenus sur membrane poly-acrylo-nitrile]. Nouvelle Presse Medicale 1977;6(13):1117-20. [MEDLINE: 850622]
265. Vaslaki L, Weber C, Mitteregger R, Falkenhagen D. No difference in cytokine induction between patients on on-line hemodiafiltration (HDF) and low-flux HD [abstract]. International Journal of Artificial Organs 1998;21(10):609. [CENTRAL: CN-00321994]
266. Vaslaki L, Weber C, Mitteregger R, Falkenhagen D. Cytokine induction in patients undergoing regular online hemodiafiltration treatment. Artificial Organs 2000;24(7):514-8. [MEDLINE: 10916061]
267. Vaslaki L, Major L, Berta K, Karatson A, Misz M, Ladanyi E, et al. Impact of convection on online hemodiafiltration on blood concentration of lipids [abstract no: PUB237]. Journal of the American Society of Nephrology 2002;13(September, Program & Abstracts):718A. [CENTRAL: CN-00448171]
268. Vaslaki L, Major L, Berta K, Karatson A, Misz M, Ladanyi E, et al. The impact of convection in online hemodiafiltration on blood concentration of advanced glycation end products [abstract no: M383]. Nephrology Dialysis Transplantation 2002;17(Suppl 1):154. [CENTRAL: CN-00509536]
269. Vaslaki L, Major L, Berta K, Karatson A, Misz M, Pethoe F, et al. Decrease of serum phosphate with on-line haemodiafiltration [abstract]. Nephrology Dialysis Transplantation 2003;18(Suppl 4):194. [CENTRAL: CN-00448172]
270. Vaslaki LR, Berta K, Major L, Weber V, Weber C, Wojke R, et al. On-line hemodiafiltration does not induce inflammatory response in end-stage renal disease patients: results from a multicenter cross-over study. Artificial Organs 2005;29(5):406-12. [MEDLINE: 15854217]
271. Wang C, Lou TQ, Tang H, Chen ZJ, Yin PD, Yu XQ. Clearance effect of different blood purification techniques on parathyroid hormone in renal function failure patients on maintenance hemodialysis. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue [Chinese Critical Care Medicine] 2004;16(12):753-5. [MEDLINE: 15585154]
272. Wizemann V, Kulz M, Techert F, Nederlof B. Efficacy of haemodiafiltration. Nephrology Dialysis Transplantation 2001;16 Suppl 4:27-30. [MEDLINE: 11402094]
273. Zehnder C, Gutzwiller JP, Renggli K. Hemodiafiltration--a new treatment option for hyperphosphatemia in hemodialysis patients. Clinical Nephrology 1999;52(3):152-9. [MEDLINE: 10499310]
274. Zimmerman DL, Swedko PJ, Posen GA, Burns KD. Daily hemofiltration with a simplified method of delivery. ASAIO Journal 2003;49(4):426-9. [MEDLINE: 12918585]
275. Zucchelli P, Santoro A, Fusaroli M, Borghi M. Biofiltration in uremia. Kidney International - Supplement 1988;24:S141-4. [MEDLINE: 3163036]
276. Beerenhout C, Dejagere T, van der Sande FM, Bekers O, Leunissen KM, Kooman JP. Haemodynamics and electrolyte balance: a comparison between on-line pre-dilution haemofiltration and haemodialysis. Nephrology Dialysis Transplantation 2004;19(9):2354-9. [MEDLINE: 15266029]
277. Bellien J, Freguin-Bouilland C, Joannides R, Hanoy M, Remy-Jouet I, Monteil C, et al. High-efficiency on-line haemodiafiltration improves conduit artery endothelial function compared with high-flux haemodialysis in end-stage renal disease patients. Nephrology Dialysis Transplantation 2014;29(2):414-22. [MEDLINE: 24235073]
278. Cornelis T, van der Sande FM, Eloot S, Cardinaels E, Bekers O, Damoiseaux J, et al. Acute hemodynamic response and uremic toxin removal in conventional and extended hemodialysis and hemodiafiltration: a randomized crossover study. American Journal of Kidney Diseases 2014;64(2):247-56. [MEDLINE: 24698199]
279. de Sequera P, Albalate M, Perez-Garcia R, Corchete E, Puerta M, Ortega M, et al. A comparison of the effectiveness of two online haemodiafiltration modalities: mixed versus post-dilution. Nefrologia 2013;33(6):779-87. [MEDLINE: 24241365]
280. Francisco RC, Aloha M, Ramon PS. Effects of high-efficiency postdilution online hemodiafiltration and high-flux hemodialysis on serum phosphorus and cardiac structure and function in patients with end-stage renal disease. International Urology & Nephrology 2013;45(5):1373-8. [MEDLINE: 23143753]
281. Gonzalez-Diez B, Cavia M, Torres G, Abaigar P, Camarero V, Muniz P. The effects of 1-year treatment with a haemodiafiltration with on-line regeneration of ultrafiltrate (HFR) dialysis on biomarkers of oxidative stress in patients with chronic renal failure. Molecular Biology Reports 2012;39(1):629-34. [MEDLINE: 21603859]
282. Krieter DH, Fischer R, Lemke HD, Merget K, Canaud B, Wanner C. Endothelial progenitor cells (EPCs) in different dialysis procedures [abstract no: TH-PO399]. Journal of the American Society of Nephrology 2009;20(Abstracts):206A.
283. Krieter DH, Fischer R, Merget K, Lemke HD, Morgenroth A, Canaud B, et al. Endothelial progenitor cells in patients on extracorporeal maintenance dialysis therapy. Nephrology Dialysis Transplantation 2010;25(12):4023-31. [MEDLINE: 20980359]
284. Cancarini G. Tolerance to hemodialysis in insulin-requiring diabetic patients: a prospective randomized, cross-over multicenter study between bicarbonate dialysis (BD) and blood volume controlled acetate-free biofiltration (BVC-AFB). clinicaltrials.gov/ct2/show/NCT01098149 (accessed 18 February 2015).
285. Canaud B. Tolerance of "on Line" hemodiafiltration and impact on morbidity and cardiovascular risk factors in chronic renal failure patients. clinicaltrials.gov/ct2/show/NCT01327391 (accessed 18 February 2015).
286. Johansen N, Jensen D. Brain swelling during hemodialysis a comparison of how low flux hemodialysis and pre-dilution hemodiafiltration affects acute brain volume changes. clinicaltrials.gov/ct2/show/NCT01396863 (accessed 18 February 2015).
287. Vanholder R. Solute removal with high volume hemodiafiltration versus long high flux hemodialysis. clinicaltrials.gov/ct2/show/NCT01445366 (accessed 18 February 2015).
288. Levesque R, Caron L. Prospective randomized study comparing the hemodiafiltration on-line and conventional hemodialysis in terms of cost-benefit. clinicaltrials.gov/ct2/show/NCT02374372 (accessed 31 March 2015).
289. Australia, New Zealand Dialysis, Transplant Registry. 35th Annual Report 2012. Chapter 5. Haemodialysis (including home haemodialysis). www.anzdata.org.au/anzdata/AnzdataReport/35thReport/2012c05_haemodialysis_v2.11.pdf (accessed 28 March 2015).
290. Arizono K, Nomura K, Motoyama T, Matsushita Y, Matsuoka K, Miyazu R, et al. Use of ultrapure dialysate in reduction of chronic inflammation during hemodialysis. Blood Purification 2004;22 Suppl 2:26-9. [MEDLINE: 15655319]
291. Daugirdas JT. Dialysis hypotension: a hemodynamic analysis. Kidney International 1991;39(2):233-46. [MEDLINE: 2002637]
292. Tattersall J, Martin-Malo A, Pedrini L, Basci A, Canaud B, Fouque D, et al. EBPG guidelines on dialysis strategies. Nephrology Dialysis Transplantation 2007;22(Suppl 2):ii5-ii21.
293. Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple graphical test. BMJ 1997;315(7109):629-34. [MEDLINE: 9310563]
294. ERA-EDTA Registry. ERA-EDTA Registry Annual Report 2010. Academic Medical Centre, Department of Medical Informatics, Amsterdam, The Netherlands. 2010. www.era-edta-reg.org/files/annualreports/pdf/AnnRep2010.pdf (accessed 28 March 2105).
295. Guerin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrology Dialysis Transplantation 2000;15(7):1014-21. [MEDLINE: 10862640]
296. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383-94. [MEDLINE: 21195583]
297. Henderson LW, Besarab A, Michaels A, Bluemle Jr LW. Blood purification by ultrafiltration and fluid replacement (diafiltration). Hemodialysis International 2004;8(1):10-8. [MEDLINE: 19379396]
298. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. [MEDLINE: 12958120]
299. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
300. Liabeuf S, Lenglet A, Desjardins L, Neirynck N, Glorieux G, Lemke HD, et al. Plasma beta-2 microglobulin is associated with cardiovascular disease in uremic patients. Kidney International 2012;82(12):1297-303. [MEDLINE: 22895515]
301. Locatelli F, Di Filippo S, Manzoni C. Removal of small and middle molecules by convective techniques. Nephrology Dialysis Transplantation 2000;15 Suppl 2:37-44. [MEDLINE: 11051036]
302. Murtagh FE, Addington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal disease: a systematic review. Advances in Chronic Kidney Disease 2007;14(1):82-99. [MEDLINE: 17200048]
303. Schmidt M. Haemodiafiltration. Haemofiltration. Berlin: Springer, 1986:265-71.
304. Susantitaphong P, Siribamrungwong M, Jaber BL. Convective therapies versus low-flux hemodialysis for chronic kidney failure: a meta-analysis of randomized controlled trials. Nephrology Dialysis Transplantation 2013;28(11):2859-74. [MEDLINE: 24081858]
305. Sztajzel J, Ruedin P, Stoermann C, Monin C, Schifferli J, Leski M, et al. Effects of dialysate composition during hemodialysis on left ventricular function. Kidney International - Supplement 1993;41:S60-6. [MEDLINE: 8320947]
306. US Renal Data System. USRDS 2011 Annual Data Report. Atlas of End-Stage Renal Disease in the United States, 2011. Bethesda MD National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. www.usrds.org/atlas11.aspx (accessed 28 March 2015).
307. Vilar E, Fry AC, Wellsted D, Tattersall JE, Greenwood RN, Farrington K. Long-term outcomes in online hemodiafiltration and high-flux hemodialysis: a comparative analysis. Clinical Journal of The American Society of Nephrology: CJASN 2009;4(12):1944-53. [MEDLINE: 19820129]
308. Zucchelli P, Santoro A, Ferrari G, Spongano M. Acetate-free biofiltration: hemodiafiltration with base-free dialysate. Blood Purification 1990;8(1):14-22. [MEDLINE: 2378708]
309. Rabindranath KS, Strippoli GF, Roderick P, Wallace SA, MacLeod AM, Daly C. Comparison of hemodialysis, hemofiltration, and acetate-free biofiltration for ESRD: systematic review. American Journal of Kidney Diseases 2005;45(3):437-47. [MEDLINE: 15754266]
310. Rabindranath K S, Strippoli G F, Daly C, Roderick P J, Wallace S, MacLeod A M. Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease. Cochrane Database of Systematic Reviews 2006, Issue CD006258. [DOI: ]